Overview

Efficacy and Safety of DHEA for Myotonic Dystrophy

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To test the efficacy and safety of two doses of dehydroepiandrosterone (DHEA) in adults with myotonic dystrophy
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Versailles
Collaborators:
Assistance Publique - Hôpitaux de Paris
Association Française contre les Myopathies (AFM), Paris
Treatments:
Dehydroepiandrosterone